Roth David

CIK 00015990143 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001599014

Recent Transactions

34 trades

Sale
Syros Pharmaceuticals, Inc.
Common Stock
2024-11-18$0.20/sh−12,099→ 0 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31$2.09/sh−6,776→ 12,099 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-10-31−18,875→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31+18,875→ 18,875 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2024-04-03$4.95/sh−10,451→ 0 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2024-04-02$4.98/sh−150→ 10,451 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-04-01$5.12/sh−4,732→ 10,601 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+13,333→ 15,333 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−13,333→ 26,667 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−2,000→ 4,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+2,000→ 2,000 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2023-12-12$4.95/sh−6,287→ 0 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2023-12-06$3.95/sh−6,287→ 6,287 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-11-01$2.22/sh−6,301→ 12,574 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-10-31+18,875→ 18,875 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-10-31−18,875→ 18,875 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2023-07-31$3.95/sh−7,348→ 0 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-04-03$2.58/sh−623→ 7,348 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-03-31−2,000→ 6,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-03-31+2,000→ 7,971 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-02-16+40,000→ 40,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-10-06+49,750→ 49,750 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-10-06+37,750→ 37,750 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2022-04-01$1.12/sh−27,281→ 59,719 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+200,000→ 200,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-02-15+125,000→ 125,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+80,000→ 80,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-02-17+119,000→ 119,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-02-13+94,000→ 94,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2019-02-12+87,000→ 87,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2019-02-12+75,000→ 75,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-16+75,000→ 75,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-02-10+63,500→ 63,500 total
Award
INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
2015-01-14+85,000→ 85,000 total

Companies

Recent Filings

Address

C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE

CAMBRIDGE, MA, 02139

View on SEC.gov